Stock Market LIVE Updates: Nifty at 25,550, Sensex flat; Groww IPO fully subscribed

Symphony was quoting at Rs 882.60, down Rs 56.85, or 6.05 percent.

It has touched an intraday high of Rs 940.95 and an intraday low of Rs 879.00.

It was trading with volumes of 6,920 shares, compared to its five day average of 5,428 shares, an increase of 27.49 percent.

In the previous trading session, the share closed down 0.65 percent or Rs 6.15 at Rs 939.45.

The share touched a 52-week high of Rs 1,639.95 and a 52-week low of Rs 867 on 07 November, 2024 and 15 October, 2025, respectively.

Currently, the stock is trading 46.18 percent below its 52-week high and 1.8 percent above its 52-week low.

Market capitalisation stands at Rs 6,060.94 crore.

#1 Loss narrows to Rs 90.9 crore Vs loss of Rs 138.7 crore, YoY

#2 Revenue soars 7.5 percent to Rs 1,491.8 crore Vs Rs 1,387.4 crore, YoY

Aditya Birla Fashion & Retail was quoting at Rs 78.98, down Rs 5.20, or 6.18 percent.

It has touched an intraday high of Rs 82.30 and an intraday low of Rs 78.60.

It was trading with volumes of 1,157,357 shares, compared to its five day average of 258,446 shares, an increase of 347.81 percent.

In the previous trading session, the share closed down 1.31 percent or Rs 1.12 at Rs 84.18.

The share touched a 52-week high of Rs 325.25 and a 52-week low of Rs 72.04 on 02 December, 2024 and 13 June, 2025, respectively.

Currently, the stock is trading 75.72 percent below its 52-week high and 9.63 percent above its 52-week low.

Market capitalisation stands at Rs 9,639.67 crore.

#1 Reported 24 percent YoY revenue growth & adjusted EBITDA of Rs 180 crore, slightly above estimates

#2 PAT of Rs 21 crore impacted by write-off of gaming JV loans due to regulation changes

#3 Encouraged by growth options in wealth, lending & international segments

#4 Strong core business & new ventures could drive 24 percent CAGR in revenue & margin expansion over FY25-28

#1 Profit grows 13.2 percent to Rs 52.7 crore Vs Rs 46.5 crore, YoY

#2 Revenue increases 22.7 percent to Rs 429.2 crore Vs Rs 349.8 crore, YoY

Metropolis Healthcare was quoting at Rs 2,032.80, up Rs 0.85, or 0.04 percent.

It has touched an intraday high of Rs 2,124.05 and an intraday low of Rs 2,009.50.

It was trading with volumes of 13,541 shares, compared to its five day average of 3,549 shares, an increase of 281.50 percent.

In the previous trading session, the share closed up 1.37 percent or Rs 27.50 at Rs 2,031.95.

The share touched a 52-week high of Rs 2,259.30 and a 52-week low of Rs 1,383.70 on 03 September, 2025 and 07 April, 2025, respectively.

Currently, the stock is trading 10.03 percent below its 52-week high and 46.91 percent above its 52-week low.

Market capitalisation stands at Rs 10,534.37 crore.

Godrej Properties was quoting at Rs 2,259.05, down Rs 33.35, or 1.45 percent.

It has touched an intraday high of Rs 2,336.75 and an intraday low of Rs 2,256.40.

It was trading with volumes of 10,963 shares, compared to its five day average of 17,612 shares, a decrease of -37.75 percent.

In the previous trading session, the share closed down 0.72 percent or Rs 16.70 at Rs 2,292.40.

The share touched a 52-week high of Rs 3,034.95 and a 52-week low of Rs 1,869.50 on 18 December, 2024 and 07 April, 2025, respectively.

Currently, the stock is trading 25.57 percent below its 52-week high and 20.84 percent above its 52-week low.

Market capitalisation stands at Rs 68,044.02 crore.

#1 Profit zooms 98.1 percent to Rs 31.1 crore Vs Rs 15.7 crore, YoY

#2 Revenue surges 40.2 percent to Rs 225.3 crore Vs Rs 160.7 crore, YoY

Apollo Micro Systems was quoting at Rs 269.15, down Rs 8.75, or 3.15 percent.

It has touched an intraday high of Rs 291.75 and an intraday low of Rs 268.50.

It was trading with volumes of 835,734 shares, compared to its five day average of 339,193 shares, an increase of 146.39 percent.

In the previous trading session, the share closed down 0.18 percent or Rs 0.50 at Rs 277.90.

The share touched a 52-week high of Rs 354.65 and a 52-week low of Rs 90.40 on 17 September, 2025 and 21 November, 2024, respectively.

Currently, the stock is trading 24.11 percent below its 52-week high and 197.73 percent above its 52-week low.

Market capitalisation stands at Rs 9,033.74 crore.

October marked a reversal of the sustained selling by FIIs seen in the previous three months.For October  FIIs bought equity for Rs 3902 crores through the exchanges.

However, this figure includes some bulk deals too. The trend of sustained buying/ investing through the primary continued in October too with a buy figure of Rs 10707 crores.

The red hot IPO market and the high premium investors are willing to pay for new issues are encouraging FIIs to invest through the primary market.

For 2025, so far, total FII investment through the primary market stands at Rs 54292 crores. This is in sharp contrast to the total sell figure through exchanges till the end of October at Rs 194201 crores. ( Source: NSDL)

The aggregate buy figure through the exchanges in October doesn’t mean that the FIIs will continue to be in buy mode, going forward. The relatively higher valuations in India may prompt FIIs to sell again. Whether FIIs will buy or sell will depend on the trajectory of India’s corporate sector’s earnings growth.

There are clear signs of earnings recovery now. If the brisk demand conditions in the market sustains, earnings will improve, which, in turn, will make valuations fair. In such a scenario FIIs will turn buyers.

#1 Profit jumps 8.7 percent to Rs 165.3 crore Vs Rs 152 crore, YoY

#2 Revenue surges 18.8 percent to Rs 2,761.9 crore Vs Rs 2,325.6 crore, YoY

Motherson Sumi Wiring India was quoting at Rs 47.01, up Rs 0.04, or 0.09 percent.

It has touched an intraday high of Rs 48.80 and an intraday low of Rs 46.95.

It was trading with volumes of 298,948 shares, compared to its five day average of 237,669 shares, an increase of 25.78 percent.

In the previous trading session, the share closed down 1.43 percent or Rs 0.68 at Rs 46.97.

The share touched a 52-week high of Rs 50.50 and a 52-week low of Rs 30.71 on 09 September, 2025 and 28 February, 2025, respectively.

Currently, the stock is trading 6.91 percent below its 52-week high and 53.08 percent above its 52-week low.

Market capitalisation stands at Rs 31,175.44 crore.

Apollo Hospitals Enterprise, Lupin, Life Insurance Corporation of India, ABB India, UPL, Zydus Lifesciences, Abbott India, Amber Enterprises India, Amara Raja Energy & Mobility, Aster DM Healthcare, Cholamandalam Investment and Finance Company, Crompton Greaves Consumer Electricals, Cummins India, Godrej Properties, Hexaware Technologies, Mankind Pharma, Multi Commodity Exchange of India, Saatvik Green Energy, and Smartworks Coworking Spaces will announce their quarterly earnings on November 6.

The Sensex was up 20.43 points or 0.02 percent at 83,479.58, and the Nifty was down 39.95 points or 0.16 percent at 25,557.70. About 1042 shares advanced, 2624 shares declined, and 126 shares unchanged.

#1 Profit rises 1.5 percent to Rs 213.2 crore Vs Rs 210.1 crore, YoY

#2 Revenue soars 9.4 percent to Rs 3,005.8 crore Vs Rs 2,746.7 crore, YoY

Deepak Fertilisers And Petrochemicals Corporation was quoting at Rs 1,434.75, down Rs 69.10, or 4.59 percent.

It has touched an intraday high of Rs 1,471.00 and an intraday low of Rs 1,421.00.

It was trading with volumes of 14,463 shares, compared to its five day average of 10,297 shares, an increase of 40.46 percent.

In the previous trading session, the share closed up 1.15 percent or Rs 17.10 at Rs 1,503.85.

The share touched a 52-week high of Rs 1,776.95 and a 52-week low of Rs 888.25 on 03 July, 2025 and 03 March, 2025, respectively.

Currently, the stock is trading 19.26 percent below its 52-week high and 61.53 percent above its 52-week low.

Market capitalisation stands at Rs 18,111.97 crore.

#1 Profit grows 12 percent to Rs 27.5 crore Vs Rs 24.6 crore, YoY

#2 Revenue increases 8.4 percent to Rs 3,032 crore Vs Rs 2,796.8 crore, YoY

TeamLease Services was quoting at Rs 1,700.50, up Rs 14.75, or 0.87 percent.

It has touched an intraday high of Rs 1,764.50 and an intraday low of Rs 1,690.00.

It was trading with volumes of 1,643 shares, compared to its five day average of 321 shares, an increase of 411.52 percent.

In the previous trading session, the share closed down 0.97 percent or Rs 16.55 at Rs 1,685.75.

The share touched a 52-week high of Rs 3,100.20 and a 52-week low of Rs 1,641.60 on 06 January, 2025 and 07 April, 2025, respectively.

Currently, the stock is trading 45.15 percent below its 52-week high and 3.59 percent above its 52-week low.

Market capitalisation stands at Rs 2,851.55 crore.

QIB – 0.10 times

NII - 1.33 times

Retail – 3.66 times

Overall – 1.09 times

#1 Profit falls 23.5 percent to Rs 206.4 crore Vs Rs 270 crore, YoY

#2 Revenue rises 1.9 percent to Rs 2,827.5 crore Vs Rs 2,774.6 crore, YoY

Berger Paints India was quoting at Rs 546.60, up Rs 9.10, or 1.69 percent.

It has touched an intraday high of Rs 554.20 and an intraday low of Rs 529.25.

It was trading with volumes of 79,185 shares, compared to its five day average of 27,909 shares, an increase of 183.73 percent.

In the previous trading session, the share closed down 0.30 percent or Rs 1.60 at Rs 537.50.

The share touched a 52-week high of Rs 604.60 and a 52-week low of Rs 437.80 on 03 July, 2025 and 30 December, 2024, respectively.

Currently, the stock is trading 9.59 percent below its 52-week high and 24.85 percent above its 52-week low.

Market capitalisation stands at Rs 63,727.81 crore.

Coal should remain a key driver of India's energy security and help to meet the evening peak demand.

Adani Power is India's largest IPP and second-largest thermal developer (after NTPC), with market share of 8% in both coal capacity and generation.

Research house expect APL to be one of the largest beneficiaries of thermal capacity addition, and see its market share reaching 15% by F32 with a 41.9GW portfolio (2.5x vs. F25).

Tata Elxsi and GSMA have signed a Memorandum of Understanding (MoU) under the GSMA Fusion initiative to help accelerate enterprise API adoption.

The collaboration also includes a global Statement of Requirements which aims to help mobile operators unlock new revenue streams by monetizing their networks through standardized APIs, enabling enterprise-ready services across key

industries such as automotive, industrial, healthcare, and entertainment.

Despite the IPO being a 100% Offer for Sale (OFS), the issue witnessed subscription demand above street expectations, reflecting strong investor interest.

While considering the current muted market sentiment, listing was very much flat on the issue price. Decent flat listing give away a great opportunity for long term investors  as we continue to believes that Orkla India, a market-leading packaged food and spices company backed by iconic brands such as MTR and Eastern, presents a compelling long-term structural growth story. The strong response to the issue underscores confidence in the company’s fundamentals and its ability to capitalize on the growing demand for convenience foods across key geographies.

So allotted investors are advised to hold the stock from a long-term investment perspective, while being mindful of inherent market risks. For non-allotted investors, Mehta Equities suggests a ‘Wait and Watch’ approach to evaluate any post-listing correction as a potential entry opportunity.

Indoco Remedies was quoting at Rs 269.75, down Rs 3.45, or 1.26 percent.

It has touched an intraday high of Rs 277.00 and an intraday low of Rs 268.55.

It was trading with volumes of 1,231 shares, compared to its five day average of 1,235 shares, a decrease of -0.34 percent.

In the previous trading session, the share closed down 0.02 percent or Rs 0.05 at Rs 273.20.

The share touched a 52-week high of Rs 353.80 and a 52-week low of Rs 190.00 on 03 December, 2024 and 28 February, 2025, respectively.

Currently, the stock is trading 23.76 percent below its 52-week high and 41.97 percent above its 52-week low.

Market capitalisation stands at Rs 2,488.39 crore.

#1 Q2 EBITDA 5 percent above estimates, driven by domestic port margin

#2 Strategy focused on EBITDA growth through integrated logistics

#1 EBITDA/PAT 10 percent/7 percent above estimates

#2 Strong India & innovation medicines growth

#3 New US launches to drive FY27 growth

#1 Profit stands at Rs 154.8 crore Vs loss of Rs 138.5 crore, YoY

#2 Revenue surges 95 percent to Rs 735.3 crore Vs Rs 377 crore, YoY

Chalet Hotels was quoting at Rs 925.55, down Rs 35.45, or 3.69 percent.

It has touched an intraday high of Rs 961.95 and an intraday low of Rs 910.20.

It was trading with volumes of 24,809 shares, compared to its five day average of 19,197 shares, an increase of 29.24 percent.

In the previous trading session, the share closed up 0.19 percent or Rs 1.85 at Rs 961.

The share touched a 52-week high of Rs 1,080 and a 52-week low of Rs 643.65 on 01 August, 2025 and 18 February, 2025, respectively.

Currently, the stock is trading 14.3 percent below its 52-week high and 43.8 percent above its 52-week low.

Market capitalisation stands at Rs 20,240.43 crore.

The Sensex was up 19.31 points or 0.02 percent at 83,478.46, and the Nifty was down 36.45 points or 0.14 percent at 25,561.20. About 1029 shares advanced, 2544 shares declined, and 134 shares unchanged.

#1 Profit spikes 101.7 percent to Rs 121.4 crore Vs Rs 60.2 crore, YoY

#2 Revenue zooms 58.4 percent to Rs 906.2 crore Vs Rs 572.1 crore, YoY

Kaynes Technology India was quoting at Rs 6,558.05, down Rs 88.05, or 1.32 percent.

It has touched an intraday high of Rs 6,899.95 and an intraday low of Rs 6,510.50.

It was trading with volumes of 35,157 shares, compared to its five day average of 26,893 shares, an increase of 30.73 percent.

In the previous trading session, the share closed down 0.07 percent or Rs 4.90 at Rs 6,646.10.

The share touched a 52-week high of Rs 7,824.95 and a 52-week low of Rs 3,835.00 on 01 January, 2025 and 11 February, 2025, respectively.

Currently, the stock is trading 16.19 percent below its 52-week high and 71.01 percent above its 52-week low.

Market capitalisation stands at Rs 43,910.80 crore.

#1 Healthy loan growth & stronger revenue trajectory are key positives

#2 Stable asset quality, EPS upgraded 6-9 percent for FY26–28

#3 Strong core PPoP growth warrants higher valuation multiples

#1 Q2FY26 EBITDAR & PAT missed estimates due to MTM FX losses, though operationally strong

#2 Yield & revenue above estimates

#3 Management increased FY26 ASK growth guidance to early teens on international expansion

#4 Demand outlook stable, Q3FY26 unit revenue expected flat to slightly higher YoY

AXISCADES Aersopace & Technologies and Electronic Bird Control an innovative French drone company, have formalized a strategic Memorandum of Understanding (MoU) to bring the E-Raptor, a state-of-the-art drone, ingeniously crafted to resemble a falcon, to the Indian market for both military and civilian applications.

#1 Profit increases 15.8 percent to Rs 160.3 crore Vs Rs 138.4 crore, YoY

#2 Net interest income soars 15.3 percent to Rs 423.6 crore Vs Rs 367.5 crore, YoY

#3 Provisions & contingencies zoom 357.6 percent to Rs 63.7 crore Vs Rs 13.9 crore, YoY

#4 Gross NPA falls to 1.81 percent Vs 1.84 percent, QoQ

#5 Net NPA declines to 0.52 percent Vs 0.66 percent, QoQ

#1 Profit grows 18.4 percent to Rs 129.8 crore Vs Rs 109.6 crore, YoY

#2 Revenue jumps 21.4 percent to Rs 303.7 crore Vs Rs 250.1 crore, YoY

International Gemmological Institute India was quoting at Rs 359.50, up Rs 24.35, or 7.27 percent.

It has touched an intraday high of Rs 361.30 and an intraday low of Rs 342.75.

In the previous trading session, the share closed down 2.47 percent or Rs 8.50 at Rs 335.15.

The share touched a 52-week high of Rs 642.30 and a 52-week low of Rs 282 on 09 January, 2025 and 12 March, 2025, respectively.

Currently, the stock is trading 44.03 percent below its 52-week high and 27.48 percent above its 52-week low.

Market capitalisation stands at Rs 15,536.14 crore.

The company has signed an agreement with RSWM for the supply of 60 MW of renewable energy to RSWM’s multiple plant locations. RSWM invested Rs 60 crore under the Group Captive Scheme with a renewable generation company (genco) for the supply of 31.53 crore units of green power per annum to its manufacturing facilities across Rajasthan.

With this addition, the contribution of renewable energy in RSWM’s total energy requirement will rise from the current 33% to 70% in the near future (two-thirds of its total energy mix).

The revenue of the company declined 43% at Rs 690 crore versus Rs 1,214 crore, YoY.

Eternal was quoting at Rs 309.35, down Rs 4.10, or 1.31 percent.

It has touched an intraday high of Rs 311.70 and an intraday low of Rs 306.50.

It was trading with volumes of 358,814 shares, compared to its five day average of 2,357,194 shares, a decrease of -84.78 percent.

In the previous trading session, the share closed down 2.79 percent or Rs 9.00 at Rs 313.45.

The share touched a 52-week high of Rs 368.40 and a 52-week low of Rs 189.60 on 16 October, 2025 and 07 April, 2025, respectively.

Currently, the stock is trading 16.03 percent below its 52-week high and 63.16 percent above its 52-week low.

Market capitalisation stands at Rs 298,533.60 crore.

#1 Reported EBITDA of Rs 140 crore in Q2FY26 vs adjusted EBITDA estimate of Rs 130 crore

#2 Company stopped disclosing ESOP expenses, a direct comparison is difficult, but it was clearly a beat

#3 Payment GMV growth of 6 percent QoQ was largely in-line with the estimate

#4 Net take rate was 0.5 bps higher than estimates, partly due to early festive season

#5 Loan distribution revenue was healthy but marketing services revenue remained weak

#6 Company continues to focus on opex rationalisation

#7 Company took a one-time Rs 190 crore hit from writing off a loan to its online gaming JV following regulatory changes

The company reported total sales of 2,835 units in the month of October, growing 32.1% compared to 2,146 units sold in the same month last year.

Gujarat Narmada Valley Fertilizers and Chemicals Company

The Board has approved the appointment of Manoj Kumar Das, IAS, as Director and Chairman of the company.

#1 Profit falls 12 percent to Rs 84.3 crore Vs Rs 95.8 crore, YoY

#2 Revenue increases 4.8 percent to Rs 2,567.4 crore Vs Rs 2,448.8 crore, YoY

The Sensex was up 239.69 points or 0.29 percent at 83,698.84, and the Nifty was up 31.65 points or 0.12 percent at 25,629.30. About 1237 shares advanced, 2101 shares declined, and 165 shares unchanged.

Zydus today announced that the USFDA has granted Orphan Drug Designation (ODD) to Desidustat, a novel oral HIF-PHI, for the treatment of betathalassemia.

The USFDA's Office of Orphan Drug Products grants orphan status to support development of medicines for the treatment of rare diseases that affect fewer than 200,000 people in the United States.

#1 Profit jumps 23.8 percent to Rs 350.2 crore Vs Rs 282.9 crore, YoY

#2 Revenue soars 16.8 percent to Rs 29,075.6 crore Vs Rs 24,895.6 crore, YoY

The company's wholly owned subsidiary, Relonchem in the UK, has received marketing authorization for its product Exemestane 25mg film-coated tablets from the UK MHRA. Exemestane tablets are used to treat hormone-positive breast cancer in postmenopausal women.

Marksans Pharma was quoting at Rs 187.95, up Rs 1.20, or 0.64 percent.

It has touched an intraday high of Rs 193.30 and an intraday low of Rs 186.85.

It was trading with volumes of 59,211 shares, compared to its five day average of 100,977 shares, a decrease of -41.36 percent.

In the previous trading session, the share closed down 1.94 percent or Rs 3.70 at Rs 186.75.

The share touched a 52-week high of Rs 358.50 and a 52-week low of Rs 162.05 on 05 December, 2024 and 07 October, 2025, respectively.

Currently, the stock is trading 47.57 percent below its 52-week high and 15.98 percent above its 52-week low.

Market capitalisation stands at Rs 8,517.21 crore.

The company has received an Establishment Inspection Report (EIR) from the USFDA (US Food and Drug Administration) for its manufacturing facility in SEZ II, Ahmedabad.

The USFDA conducted an inspection at the group’s manufacturing plant during August 11-14, 2025. The inspection was a Pre-Approval Inspection (PAI). The USFDA has concluded this inspection as closed, with no observations. The EIR has classified the facility as No Action Indicated (NAI).

Zydus Lifesciences was quoting at Rs 969.30, down Rs 3.55, or 0.36 percent.

It has touched an intraday high of Rs 985.95 and an intraday low of Rs 967.30.

It was trading with volumes of 7,906 shares, compared to its five day average of 38,309 shares, a decrease of -79.36 percent.

In the previous trading session, the share closed down 0.81 percent or Rs 7.90 at Rs 972.85.

The share touched a 52-week high of Rs 1,059.00 and a 52-week low of Rs 797.05 on 19 September, 2025 and 07 April, 2025, respectively.

Currently, the stock is trading 8.47 percent below its 52-week high and 21.61 percent above its 52-week low.

Market capitalisation stands at Rs 97,534.26 crore.

The IT services, consulting, and business solutions company has expanded its 18-year partnership with ABB to modernize ABB’s global hosting operations, simplify its IT landscape, and strengthen its digital foundation to drive resilience and innovation.

Tata Consultancy Services was quoting at Rs 3,001.50, up Rs 11.70, or 0.39 percent.

It has touched an intraday high of Rs 3,017.80 and an intraday low of Rs 2,989.80.

It was trading with volumes of 10,056 shares, compared to its five day average of 111,671 shares, a decrease of -90.99 percent.

In the previous trading session, the share closed down 0.87 percent or Rs 26.30 at Rs 2,989.80.

The share touched a 52-week high of Rs 4,494 and a 52-week low of Rs 2,867.55 on 10 December, 2024 and 01 October, 2025, respectively.

Currently, the stock is trading 33.21 percent below its 52-week high and 4.67 percent above its 52-week low.

Market capitalisation stands at Rs 1,085,968.97 crore.

#1 Loss stands at Rs 50.4 crore Vs profit of Rs 10.2 crore, YoY

#2 Revenue increases 16.9 percent to Rs 2,559.3 crore Vs Rs 2,189.7 crore, YoY

#3 Vivek Pabari to take over as Chief Financial Officer of the company

#1 Profit sinks 48.6 percent to Rs 284.9 crore Vs Rs 554.6 crore, YoY

#2 Revenue rises 11.8 percent to Rs 2,040.9 crore Vs Rs 1,826.1 crore, YoY

Indian Hotels Company was quoting at Rs 720.95, down Rs 22.50, or 3.03 percent.

It has touched an intraday high of Rs 736.30 and an intraday low of Rs 711.20.

It was trading with volumes of 82,108 shares, compared to its five day average of 63,627 shares, an increase of 29.05 percent.

It was trading with volumes of 82,108 shares, compared to its thirty day average of 64,658 shares, an increase of 26.99 percent.

In the previous trading session, the share closed down 0.48 percent or Rs 3.60 at Rs 743.45.

The share touched a 52-week high of Rs 894.15 and a 52-week low of Rs 678.90 on 30 December, 2024 and 07 November, 2024, respectively.

Currently, the stock is trading 19.37 percent below its 52-week high and 6.19 percent above its 52-week low.

Market capitalisation stands at Rs 102,622.35 crore.

2.11 crore shares (3.45 percent equity) of RBL Bank worth Rs 678 crore change hands at Rs 321 per share in block deal window.

#1 Profit zooms 23.1 percent to Rs 654.5 crore Vs Rs 531.5 crore, YoY

#2 Revenue grows 3.7 percent to Rs 4,840.6 crore Vs Rs 4,667.6 crore, YoY

#3 Board appoints Rakshit Hargave as an Additional Whole-Time Director and Chief Executive Officer of Britannia

Britannia Industries was quoting at Rs 6,099.15, up Rs 212.45, or 3.61 percent.

It has touched an intraday high of Rs 6,197.75 and an intraday low of Rs 6,094.70.

It was trading with volumes of 11,383 shares, compared to its five day average of 23,057 shares, a decrease of -50.63 percent.

In the previous trading session, the share closed up 1.12 percent or Rs 65.30 at Rs 5,886.70.

The share touched a 52-week high of Rs 6,336.95 and a 52-week low of Rs 4,506.50 on 04 September, 2025 and 04 March, 2025, respectively.

Currently, the stock is trading 3.75 percent below its 52-week high and 35.34 percent above its 52-week low.

Market capitalisation stands at Rs 146,909.19 crore.

Inox Wind has secured new orders aggregating to 229 MW. The company has received a 160 MW order (112 MW firm order with an option to extend by an additional 48 MW) from a leading Indian IPP player for the supply of its 3.3 MW wind turbine generators, for projects being developed by the customer across multiple sites.

The order also includes limited-scope EPC services and multi-year operations & maintenance (O&M) post commissioning. Additionally, Inox Wind has bagged a repeat order for 69 MW from another leading renewable energy player, which is a member of a large global clean energy company, for a project in Maharashtra.

This order follows a 153 MW order received earlier in March 2025 from the same customer, reflecting the growing relationship and trust built in a short period.

#1 Loss widens to Rs 2,582.1 crore Vs loss of Rs 986.7 crore, YoY

#2 Revenue grows 9.3 percent to Rs 18,555.3 crore Vs Rs 16,969.6 crore, YoY

#3 EBITDAR plunges 54.2 percent to Rs 1,114.3 crore Vs Rs 2,434 crore, YoY

#4 EBITDAR margin drops to 6 percent Vs 14.3 percent, YoY

#5 EBITDAR (excluding forex) zooms 42.5 percent to Rs 3,800.3 crore Vs Rs 2,666.8 crore, YoY

#6 EBITDAR margin (excluding forex) expands to 20.5 percent Vs 15.7 percent, YoY

Apollo Hospitals Enterprise, Lupin, Life Insurance Corporation of India, ABB India, Ola Electric Mobility, UPL, Zydus Lifesciences, Abbott India, Amber Enterprises India, Amara Raja Energy & Mobility, Aster DM Healthcare, Cholamandalam Investment and Finance Company, Crompton Greaves Consumer Electricals, Cummins India, Godrej Properties, Hexaware Technologies, Mankind Pharma, Multi Commodity Exchange of India, Saatvik Green Energy, and Smartworks Coworking Spaces will announce their quarterly earnings on November 6.

#1 Profit falls sharply to Rs 21 crore Vs Rs 928 crore, YoY

#2 Revenue grows 24.2 percent to Rs 2,061 crore Vs Rs 1,659 crore, YoY

#3 Exceptional loss at Rs 190 crore Vs exceptional gain of Rs 1,345 crore, YoY

#4 Paytm partners with Groq to power real-time AI for payments and platform intelligence

#1 Profit jumps 11.6 percent to Rs 804.6 crore Vs Rs 720.9 crore, YoY

#2 Revenue soars 26 percent to Rs 9,610.3 crore Vs Rs 7,623.3 crore, YoY

On the back of positive global cues, the Indian indices opened higher on November 6.

The Sensex was up 290.27 points or 0.35 percent at 83,749.42, and the Nifty was up 53.20 points or 0.21 percent at 25,650.85. About 1296 shares advanced, 1219 shares declined, and 251 shares unchanged.

Asian Paints, Reliance Industries, SBI, L&T, NTPC were among major gainers on the Nifty, while losers were Hindalco, Shriram Finance, Bajaj Finance, Apollo Hospitals and Dr Reddy's Labs.

In Tuesday’s session, the Nifty tumbled sharply, snapping its winning streak as broad-based selling hit every sector. However, Thursday’s trade could see a rebound, with Wall Street stabilising and optimism surrounding ongoing India–U.S. trade negotiations. Commerce Minister Piyush Goyal noted that talks on the proposed Bilateral Trade Agreement are progressing, though key issues remain. Yet, the Fed’s uncertain stance on rate cuts continues to weigh on sentiment, keeping markets cautious and range-bound.

Technically, strength is seen only above 26,107, with 26,903 as a key hurdle. Britannia posted a 34% YoY rise in Q2 profit, while Delhivery’s revenue grew 17% despite a loss.

Key earnings to watch include Life Insurance Corp, Chola Finance, Cummins, ABB, Apollo Hospitals, Lupin, and Godrej Properties.

The preferred trades: Nifty (25,598) — Buy at CMP, targets 25,750–26,107; Bank Nifty (57,827) — Buy at CMP, targets 58,000–58,900.

Stocks in focus: Apollo Hospitals, Britannia, Laurus Labs, and M&M, with M&M signalling a strong momentum breakout.

Yesterday’s holiday saved the Indian market getting impacted by the mild turbulence in global markets. Today the scenario is different with stability returning to markets. In the coming days the focus of the market will be the developments in the US Supreme Court which is hearing the petition against Trump tariffs. Observations by some judges that ‘President Trump had overstepped his authority’ is a significant development. If the final judgement goes in line with these observations, there will be major volatility in markets, with emerging markets, particularly India which has been targeted for steep 50 percent tariff, rallying smartly.

For the near-term, however, the resumption of sustained selling by FIIs ( Rs 15336 crores in the last five days) and increasing FII short positions will weigh on markets.

Benchmark indices are trading flat in the pre-opening session.

The Sensex was down 19.33 points or 0.02 percent at 83,439.82, and the Nifty was down 87.55 points or 0.34 percent at 25,510.10.

Promoter Anjay Ratanlal Agarwal sold 1 lakh shares in the information technology and cyber security auditing and consulting company at Rs 93.1 per share for a total of Rs 93.1 lakh to Nautilus.

In the previous trading session, the share closed down 2.92 percent or Rs 2.82 at Rs 93.74.

The share touched a 52-week high of Rs 136.67 and a 52-week low of Rs 66 on 07 October, 2025 and 18 March, 2025, respectively.

Currently, the stock is trading 31.41 percent below its 52-week high and 42.03 percent above its 52-week low.

Market capitalisation stands at Rs 120.24 crore.

Indian rupee opened higher at 88.52 per dollar on Thursday versus Tuesday's close of 88.65.

Promoter Shazad Sheriar Rustomji sold 8.08 lakh shares (equivalent to 1.01% of paid-up equity) in Stallion India at Rs 247.65 per share, valued at Rs 20.01 crore. The total promoters' shareholding in the company was 67.9 percent as of September 2025.

However, Savita Jayesh Shah acquired 4.04 lakh shares (0.5% stake), and Jayeshbhai Nagindas Shah bought 4.04 lakh shares (0.5% stake) in Stallion India at Rs 247.65 per share.

In the previous trading session, the share closed down 4.99 percent or Rs 13.00 at Rs 247.65.

The share touched a 52-week high of Rs 424.20 and a 52-week low of Rs 59.91 on 17 October, 2025 and 03 March, 2025, respectively.

Currently, the stock is trading 41.62 percent below its 52-week high and 313.37 percent above its 52-week low.

Market capitalisation stands at Rs 1,964.49 crore.

Foreign Institutional Investors (FPIs/FIIs) ended the last week of October as net sellers, dumping Indian equities worth Rs 1,067 crore. Meanwhile, Domestic Institutional Investors (DIIs) net bought Rs 1,202 crore on Tuesday, November 4, 2025, according to provisional exchange data.

DIIs bought shares worth Rs 15,835 crore and sold shares worth Rs 14,632 crore. In contrast, FIIs purchased shares valued at Rs 13,187 crore while offloading shares worth Rs 14,254 crore.

For the year so far, FIIs have been net sellers of shares worth Rs 2.43 lakh crore, while DIIs have net bought shares worth Rs 6.32 lakh crore.

In the previous trading session, the share closed down 1.38 percent or Rs 4.55 at Rs 324.00.

The share touched a 52-week high of Rs 331.80 and a 52-week low of Rs 146 on 03 November, 2025 and 20 January, 2025, respectively.

Currently, the stock is trading 2.35 percent below its 52-week high and 121.92 percent above its 52-week low.

Market capitalisation stands at Rs 19,873.79 crore.

Indian equity markets are likely to open on a flat to slightly positive note today, as suggested by the GIFT Nifty, which is trading near 25,733 — about 25 points higher. Investor sentiment remains cautiously optimistic amid mixed global cues and limited domestic triggers.

In the near term, market participants are expected to track global developments, crude oil price movements, and institutional fund flows to gauge overall direction.

In the previous session, the Nifty 50 opened flat but gradually drifted lower throughout the day, reflecting persistent profit booking and a lack of sustained buying interest at higher levels. On the technical front, immediate resistance is placed at 25,700, followed by 25,750 and 25,800, while support is expected around 25,450–25,500. These lower levels could act as potential accumulation zones for positional traders.

The Bank Nifty also mirrored the broader market’s weakness, closing 275 points lower and signaling a temporary pause in its recent recovery attempt. Key support is placed at 57,700, and a decisive break below this level could trigger further downside toward 57,500 and 57,300. On the upside, resistance lies in the 58,000–58,200 zone, and a sustained breakout above this range could extend the rebound toward 58,500.

On the institutional front, Foreign Institutional Investors (FIIs) were net sellers for the fourth consecutive session, offloading equities worth Rs 1,883 crore on November 4. In contrast, Domestic Institutional Investors (DIIs) continued their buying streak for the eighth straight session, purchasing equities worth over Rs 3,500 crore, providing some support to the market.

Given the ongoing volatility and mixed global backdrop, traders are advised to maintain a cautious buy-on-dips strategy, particularly when using leverage. Partial profit booking during rallies and the use of tight trailing stop-losses remain essential for prudent risk management.

Fresh long positions should be considered only if the Nifty sustains above the 26,100 level. While the broader undertone of the market stays cautiously bullish, close monitoring of key technical levels and global cues will be crucial in determining near-term market direction.

US-headquartered Tenneco Group-backed Tenneco Clean Air India, the automotive component maker, has decided to open its Rs 3,600-crore initial public offering (IPO) on November 12.

The IPO comprises of entirely offer-for-sale by promoter Tenneco Mauritius Holdings, with no fresh issue component, as per the Red Herring Prospectus filed with the Registrar of Companies on November 5.

The company has increased its IPO size to Rs 3,600 crore, from Rs 3,000 crore planned earlier as per DRHP filed in June 2025.

Tenneco Clean Air India will not receive funds from the IPO as all the money will go to its promoter. Read More

Sun Pharmaceutical Industries on Wednesday posted a 2.56 per cent increase in its consolidated net profit to Rs 3,118 crore for the second quarter ended September 30, aided by robust sales in India and emerging markets.

The Mumbai-based drug major reported a net profit of Rs 3,040 crore for the July-September quarter of the last fiscal.Its revenue from operations increased to Rs 14,405 crore in the September quarter against Rs 13,264 crore in the year-ago period, Sun Pharma said in a regulatory filing.”

Bengaluru-based Emmvee Photovoltaic Power, one of the largest solar PV module manufacturers in India, is set to hit Dalal Street with its Rs 2,900-crore worth initial public offering on November 11.

The company is issuing fresh shares worth Rs 2,143.9 crore, and promoters - Manjunatha Donthi Venkatarathnaiah and his wife Shubha - will be offloading Rs 756.1 worth shares via offer-for-sale. Read More

Logistics major Delhivery on November 5 slipped into the red, posting a loss of Rs 50.5 crore in the second quarter (Q2) of financial year 2025-26 (FY26), compared to a profit of Rs 10.2 crore in the same period a year ago. The Gurugram-based firm had reported a profit of Rs 91 crore in the previous quarter.

Delhivery’s revenue from operations rose almost 17 percent YoY to Rs 2,559.3 crore in Q2, up from Rs 2,189.7 crore a year ago. On a sequential basis, revenue grew from Rs 2,294 crore in Q1 FY26. Read More

Mahindra and Mahindra is likely to sell its entire 3.45% stake in the bank, with the block size likely at $78 million (Rs 682 crore) and a floor price of Rs 317 per share, reports CNBC-TV18 quoting sources.

The company's wholly owned subsidiary, Relonchem in the UK, has received marketing authorization for its product Exemestane 25mg film-coated tablets from the UK MHRA. Exemestane tablets are used to treat hormone-positive breast cancer in postmenopausal women.

Noida-based online education platform Physicswallah, which is backed by WestBridge Capital, Hornbill Capital, and GSV Ventures, has filed Red Herring Prospectus (RHP) with the Registrar Companies for launching Rs 3,480-crore IPO next week on November 11.

The one-day IPO anchor book will be launched for institutional investors on November 10, while the public issue will remain open for all investors till November 13.

The company will finalise the IPO share allotment by November 14, while Physicswallah shares will start trading on the BSE and NSE on November 18. Read More

Aditya Birla Group flagship Grasim Industries Ltd reported a standalone profit of Rs 805 crore for the July-September quarter, an increase of 12 percent year-on-year. This also represents a return to profitability for the firm, which reported a loss of Rs 721 crore for the April-June quarter, as it built up its capital expenditure-intensive paints business.

Standalone earnings before interest, taxes, depreciation, and amortisation (EBITDA) for the quarter increased slightly year-on-year to Rs 1,786 crore, due to a large dividend income component. Read More

Apollo Hospitals Enterprise, Lupin, Life Insurance Corporation of India, ABB India, Ola Electric Mobility, UPL, Zydus Lifesciences, Abbott India, Amber Enterprises India, Amara Raja Energy & Mobility, Aster DM Healthcare, Cholamandalam Investment and Finance Company, Crompton Greaves Consumer Electricals, Cummins India, Godrej Properties, Hexaware Technologies, Mankind Pharma, Multi Commodity Exchange of India, Saatvik Green Energy, and Smartworks Coworking Spaces will announce their quarterly earnings on November 6.

One97 Communications Ltd, the parent company of Paytm, on Tuesday reported a consolidated net profit of Rs 21 crore for the quarter ended September 2025 (Q2 FY26), a sharp decline from Rs 930 crore in the same period last year.

Revenue from operations rose 24 percent year-on-year to Rs 2,061 crore and 7 percent higher quarter-on-quarter from Rs 1,918 crore in Q1 FY26, driven by sustained growth in financial services and merchant payments. Read More

Markets edged lower on the weekly expiry day, with the Nifty 50 slipping 0.7% to close at 25,600. After a flat start, the index faced sustained selling pressure and gradually drifted lower through the session, eventually settling near the day’s low. Sectorally, all major indices ended in the red, with metals and IT among the top laggards. The broader markets also witnessed pressure, declining in the range of 0.46% to 0.8%, reflecting a broad risk-off sentiment.

Profit-taking across heavyweight sectors dampened overall mood, while risk appetite remained subdued amid weak global cues. Additionally, inconsistent foreign institutional investor (FII) flows further added to the cautious tone.

Technically, the Nifty retested its 20-day EMA, and a sustained move below this level could weaken the positive bias, potentially extending the corrective phase toward 25,400. On the upside, 25,800 is likely to act as an immediate hurdle. Traders are advised to align positions accordingly and maintain a strong focus on risk management until a clear directional trend emerges.